Fundraising Fox

Menten AI

YC W20 β†—

San Francisco, US Β· 2 employees Β· 7 known investors

menten.ai β†—

Menten AI develops generative AI software to design cyclic peptide therapeutics for drug targets beyond the reach of conventional small molecules and biologics. The company partners with major pharmaceutical firms to accelerate preclinical drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechAI-powered Drug DiscoveryQuantum Computingin /menten-ai@menten_aiycombinator.com β†—

Founders & leadershipΒ· Y Combinator alumni (W20)

TGTamas Gorbe
Tamas Gorbein𝕏Founder
HMHans Melo
Hans MeloinFounder

Investors Β· 7

Y Combinatorβœ“ verifiedSan Francisco Β· $500K
Khosla Venturesβœ“ verifiedMenlo Park Β· $5K – $50M
Uncork Capitalβœ“ verifiedSan Francisco Β· $3M – $5M
Alumni VenturesManchester Β· $100K – $10M
Basecamp FundManchester Β· $100K – $10M
big_bets$300K – $2M
Social Impact CapitalreportedNew York Β· $100K – $1.5M

In the news